DBS and Rodent Antidepressant- Screen Models

DBS 和啮齿动物抗抑郁药 - 筛选模型

基本信息

  • 批准号:
    7454336
  • 负责人:
  • 金额:
    $ 17.65万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2005
  • 资助国家:
    美国
  • 起止时间:
    2005-07-05 至 2010-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Depression is a prevalent neuropsychiatric illness with devastating medical and socio-economic consequences. Although many patients respond to current treatments, up to 25% do not respond, or have substantial side effects. New treatments are desperately needed. This application for Mentored Clinical Scientist Development Award responds to the NIMH Strategic Plan for Mood Disorder Research recommendation to develop experts in translational research. Animal models of depression like the Forced Swim Test (FST) predict human antidepressant activity. Almost all antidepressant drugs and electro-convulsive therapy used in daily clinical practice have been validated with the FST. Deep brain stimulation (DBS) is an invasive technique that could potentially play a role in targeted antidepressant treatment delivery in medication resistant patients. DBS is postulated to inhibit dysfunctional brain systems implicated in maladaptive responses to stress and linked to the pathophysiology of depression. At the moment, enthusiasm for applying DBS in depressed populations is limited by the ethical concern that since these dysfunctional depression networks are not fully worked out in humans, it is unclear where to implant a DBS electrode in man. That is, there is inadequate basic animal research at the moment to support the choice of a targeted area. This proposal is designed to fill several of these gaps. It offers to train the candidate to become an expert in translation depression research, with training in DBS, predictors of antidepressant response in rodents, immunocytochemistry of immediate early gene expression and advanced research methodology. The scientific study within this training award is designed to teach the candidate new methods and approaches, while also answering important questions in this area. Sprague-Dawley rats will be divided into 12 groups in a parallel double-blind design and implanted with bilateral DBS to either the centro-medial amygdala (CMA), dorsal raphe (DR), or anterior cingulate cortex (ACC). Each group will receive an intraperitoneal injection of fluoxetine (FLX) (an effective antidepressant drug) or saline (SAL) and be stimulated with either active DBS (DBS) or sham DBS (NoSTM). Rats will be tested once (FLX/DBS, FLX/NoSTM, SAL/DBS, SAL/NoSTM). FST immobility time will serve as a primary outcome measure. 30 minutes from FST start, the brains will be stained for c-fos using immunocychemistry method. C-fos profiles will serve as exploratory measures of antidepressant response and regional circuitry. This K08 expands on and complements the candidate's special expertise in clinical research of electrical neuromodulation applied to mood disorders. The knowledge from this 5-year career development award will position him to better guide future therapeutic applications of DBS. Future work will bridge between validating these findings in more comprehensive models of depression and clinical investigations of the DBS antidepressant effect in patients with treatment resistant depression.
描述(由申请人提供):抑郁症是一种普遍存在的神经精神疾病,具有破坏性的医疗和社会经济后果。尽管许多患者对目前的治疗有反应,但高达25%的患者没有反应,或者有很大的副作用。迫切需要新的治疗方法。这次申请导师临床科学家发展奖是为了响应NIMH情绪障碍研究战略计划的建议,以培养翻译研究方面的专家。像强迫游泳测试(FST)这样的抑郁症动物模型可以预测人类的抗抑郁活性。几乎所有日常临床实践中使用的抗抑郁药物和电惊厥治疗都经过了FST的验证。脑深部刺激(DBS)是一种侵入性技术,可能在耐药患者的靶向抗抑郁治疗中发挥作用。DBS被认为可以抑制功能失调的大脑系统,这些系统涉及对压力的不良适应反应,并与抑郁症的病理生理有关。目前,在抑郁人群中应用DBS的热情受到伦理担忧的限制,因为这些功能失调的抑郁网络并没有在人类身上完全解决,还不清楚在哪里植入DBS电极。也就是说,目前没有足够的基础动物研究来支持目标区域的选择。这项提议旨在填补其中的几个空白。它提供培训候选人成为翻译抑郁研究的专家,培训DBS,啮齿动物抗抑郁反应的预测因子,即刻早期基因表达的免疫细胞化学和先进的研究方法。这一培训奖项中的科学研究旨在向候选人传授新的方法和途径,同时也回答这一领域的重要问题。SD大鼠将按平行双盲设计分为12组,将双侧DBS植入杏仁中央内侧核(CMA)、中缝背侧(DR)或前扣带回(ACC)。每组均接受氟西汀(Floxetine,一种有效的抗抑郁药物)或生理盐水(SAL)的腹腔注射,并用活性DBS(DBS)或假DBS(NoSTM)刺激。对大鼠进行一次实验(FLX/DBS、FLX/NoSTM、SAL/DBS、SAL/NoSTM)。FST不动时间将作为主要结果衡量标准。FST开始30分钟后,用免疫细胞化学方法对脑组织进行c-fos染色。C-fos图谱将作为抗抑郁药物反应和区域回路的探索性指标。这本K08扩展并补充了候选人在应用于情绪障碍的电神经调节临床研究方面的特殊专业知识。从这个为期5年的职业发展奖中获得的知识将使他能够更好地指导DBS未来的治疗应用。未来的工作将在更全面的抑郁症模型中验证这些发现和临床研究DBS在难治性抑郁症患者中的抗抑郁效果之间架起桥梁。

项目成果

期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Anti-ceramidase LCL385 acutely reduces BCL-2 expression in the hippocampus but is not associated with an increase of learned helplessness in rats.
抗神经酰胺酶 LCL385 急剧降低海马中 BCL-2 的表达,但与大鼠习得性无助的增加无关。
  • DOI:
    10.1016/j.bbr.2008.07.040
  • 发表时间:
    2009
  • 期刊:
  • 影响因子:
    2.7
  • 作者:
    Nahas,Ziad;Jiang,Yan;Zeidan,YoussefH;Bielawska,Alicja;Szulc,Zdzislaw;Devane,Lindsay;Kalivas,Peter;Hannun,YusufA
  • 通讯作者:
    Hannun,YusufA
Inverse effects of oxytocin on attributing mental activity to others in depressed and healthy subjects: a double-blind placebo controlled FMRI study.
  • DOI:
    10.3389/fpsyt.2010.00134
  • 发表时间:
    2010-01-01
  • 期刊:
  • 影响因子:
    4.7
  • 作者:
    Pincus, David;Kose, Samet;Nahas, Ziad
  • 通讯作者:
    Nahas, Ziad
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Ziad Nahas其他文献

Ziad Nahas的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Ziad Nahas', 18)}}的其他基金

Clinical Core
临床核心
  • 批准号:
    10865820
  • 财政年份:
    2022
  • 资助金额:
    $ 17.65万
  • 项目类别:
Clinical Core
临床核心
  • 批准号:
    10610558
  • 财政年份:
    2022
  • 资助金额:
    $ 17.65万
  • 项目类别:
VNS Modulation of the Central Autonomic Network and its Effects on ANS
中枢自主网络的 VNS 调节及其对 ANS 的影响
  • 批准号:
    10709642
  • 财政年份:
    2022
  • 资助金额:
    $ 17.65万
  • 项目类别:
VNS Modulation of the Central Autonomic Network and its Effects on ANS
中枢自主网络的 VNS 调节及其对 ANS 的影响
  • 批准号:
    10610562
  • 财政年份:
    2022
  • 资助金额:
    $ 17.65万
  • 项目类别:
Clinical Core
临床核心
  • 批准号:
    10709634
  • 财政年份:
    2022
  • 资助金额:
    $ 17.65万
  • 项目类别:
A PILOT SAFETY AND EFFICACY STUDY OF EPIDURAL PREFRONTAL CORTICAL STIMULATION
硬膜外前额皮质刺激的试点安全性和有效性研究
  • 批准号:
    7719603
  • 财政年份:
    2008
  • 资助金额:
    $ 17.65万
  • 项目类别:
DBS and Rodent Antidepressant- Screen Models
DBS 和啮齿动物抗抑郁药 - 筛选模型
  • 批准号:
    7091507
  • 财政年份:
    2005
  • 资助金额:
    $ 17.65万
  • 项目类别:
DBS and Rodent Antidepressant- Screen Models
DBS 和啮齿动物抗抑郁药 - 筛选模型
  • 批准号:
    7240512
  • 财政年份:
    2005
  • 资助金额:
    $ 17.65万
  • 项目类别:
DBS and Rodent Antidepressant- Screen Models
DBS 和啮齿动物抗抑郁药 - 筛选模型
  • 批准号:
    6866788
  • 财政年份:
    2005
  • 资助金额:
    $ 17.65万
  • 项目类别:
Interleaved Perfrontal TMS/fMRI in Schizophrenia
交错前额 TMS/fMRI 在精神分裂症中的应用
  • 批准号:
    6694100
  • 财政年份:
    2002
  • 资助金额:
    $ 17.65万
  • 项目类别:

相似海外基金

Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 17.65万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 17.65万
  • 项目类别:
    Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 17.65万
  • 项目类别:
    Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 17.65万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 17.65万
  • 项目类别:
    Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 17.65万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 17.65万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 17.65万
  • 项目类别:
    Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 17.65万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
  • 批准号:
    484000
  • 财政年份:
    2023
  • 资助金额:
    $ 17.65万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了